ClinicalTrials.Veeva

Menu

The Impact of Obesity on Nonsurgical Periodontal Therapy

F

Federal University of Rio Grande do Sul

Status

Unknown

Conditions

Periodontitis
Periodontal Diseases
Obesity

Treatments

Drug: Placebo
Drug: Metronidazole
Procedure: Scaling and root planning

Study type

Interventional

Funder types

Other

Identifiers

NCT01405365
CNPq-402335/2008-2

Details and patient eligibility

About

The purpose of this study is to investigate the effect that obesity may have on the nonsurgical treatment (with and without the adjunct use of metronidazole) of destructive periodontal diseases (chronic periodontitis).

Full description

Normal weight (BMI 18.5-24.9 kg/m2) and obese (BMI >30 kg/m2) women will be randomly assigned to two nonsurgical periodontal treatments:

  1. scaling and root planing + placebo
  2. scaling and root planing + metronidazole

Enrollment

96 estimated patients

Sex

Female

Ages

35 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Normal weight or obese (according to BMI)
  • nonsmokers or former smokers (3 or more years)
  • no systemic diseases that may affect periodontal treatment (diabetes, osteoporosis, steroid use)
  • have 10 teeth present
  • have at least 2 teeth with probing depth 6+mm and attachment loss 4+mm

Exclusion criteria

  • Pregnancy
  • Development of diabetes or other conditions that may impair periodontal healing

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

96 participants in 2 patient groups, including a placebo group

Metronidazole
Experimental group
Treatment:
Procedure: Scaling and root planning
Drug: Metronidazole
Placebo
Placebo Comparator group
Treatment:
Procedure: Scaling and root planning
Drug: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Eduardo J Gaio, DDS; Juliano Cavagni, DDS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems